article thumbnail

What to expect from drug discovery and development in 2023

Drug Discovery World

Even when those assets are excluded, the average ROI for 2021 was still double the 2022 projections.   “Aside from Covid-19, the fall in projected ROI has been driven by a combination of factors, ranging from high-value drugs securing approvals and entering commercialisation, to an increase in cycle times for drugs still in development.